At the CRC Hannover, experts of Fraunhofer ITEM and Hannover Medical School with unique, extensive experience and capabilities work on different indications in early-phase and proof-of-concept studies. If your candidate medication requires efficacy and safety testing, please get in touch with us.
The CRC Hannover is one of Europe’s largest non-hospital clinical research centers. Occupying a three-story building with 6,000 square meters of floor space, it hosts clinical studies, patient-oriented research, epidemiological studies, and the central biobank of the Hannover Medical School.
We have a clear focus on airway research and long-standing experience in the indications of allergic rhinitis, asthma, and COPD. We offer a wide range of techniques and challenge models to conduct early-phase and proof-of-concept studies in these indications.
More recently, a world-renowned expert on idiopathic pulmonary fibrosis, Prof. Antje Prasse, joined our team, conducting clinical trials on this health condition and other rare interstitial lung diseases.